A:-Etanercept
B:-Anakinra
C:-Infliximab
D:-Cetuximab
Correct Answer:- Option-D
2:-Glycoprotein IIb/IIIa receptor antagonist is
A:-Prasugrel
B:-Ticlopidine
B:-Ticlopidine
C:-Tirofiban
D:-Cangrelor
Correct Answer:- Option-C
3:-Preferred drug in the treatment of drug induced parkinsonism
A:-Levodopa
B:-Selegiline
C:-Trihexyphenidyl
B:-Selegiline
C:-Trihexyphenidyl
D:-Tolcapone
Correct Answer:- Option-C
4:-Stimulation of which receptor will release renin?
A:-Alpha 1
B:-Alpha 2
C:-Beta 1
D:-Beta 2
B:-Alpha 2
C:-Beta 1
D:-Beta 2
Correct Answer:- Option-C
Question95:-Evolocumab is used in
A:-Hyperlipidemia
B:-Bronchial asthma
C:-Migraine
D:-Breast cancer
D:-Breast cancer
Correct Answer:- Option-A
6:-5-HT1A partial agonist among the following
A:-Ketanserin
B:-Hydroxyzine
C:-Cyproheptadine
B:-Hydroxyzine
C:-Cyproheptadine
D:-Buspirone
Correct Answer:- Option-D
7:-All of the following can be used as local anaesthetics except
A:-Dexmedetomidine
B:-Centbucridine
C:-Diphenhydramine
B:-Centbucridine
C:-Diphenhydramine
D:-Benzyl alcohol
Correct Answer:- Option-A
8:-All of the following drugs are included under RNTCP for the treatment of XDR-TB except
A:-Capreomycin
B:-Levofloxacin
B:-Levofloxacin
C:-Clofazimine
D:-Linezolid
Correct Answer:- Option-B
9:-Denosumab is used for the treatment of
A:-Rheumatoid arthritis
B:-Osteoarthritis
B:-Osteoarthritis
C:-Osteoporosis
D:-Systematic lupus erythematosus
D:-Systematic lupus erythematosus
Correct Answer:- Option-C
10:-Anthelmintic agent with immunomodulatory action
A:-Albendazole
B:-Pyrantel pamoate
B:-Pyrantel pamoate
C:-Piperazine
D:-Levamisole
D:-Levamisole
Correct Answer:- Option-D
0 Comments
Post a Comment